Common Variants at the 19p13.1 and <i>ZNF365</i> Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersFergus J. Couch, Theo A. van Os, Mia M. Gaudet et al.|Cancer Epidemiology Biomarkers & Prevention|2012Cited by 57
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyIrma Kluijt, Anna Jakubowska, Dominik Rozkrut et al.|British Journal of Cancer|2012Cited by 38
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancerAnna Öfverholm, Hans Ehrencrona, Therese Törngren et al.|BMC Cancer|2023Cited by 16
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancerAlexios Matikas, Theodoros Foukakis, Kang Wang et al.|ESMO Open|2021Cited by 12
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersFranco̧is Cornelis, Mary Beattie, Paolo Peterlongo et al.|UNC Libraries|2020Cited by 2